TABLE 1.
Types of JCV RRa found in plasma and CNS (brain and CSF) of groups with different clinical outcomes
| Clinical outcome and/or patient characteristic | Plasma
|
CNS
|
||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| No. of patients | No. of clones | No. (%) of indicated RR typea
|
No. of patients | No. of clones | No. (%) of indicated RR typea
|
|||||
| A | AL | TR | A | AL | TR | |||||
| PML progressor, HIV+/HIV− | 5 | 43 | 0 | 20 (46) | 23 (54) | 9 | 88 | 1 (1) | 12 (14) | 75 (85) |
| PML survivor, HIV+/HIV− | 2 | 12 | 9 (75) | 0 | 3 (25) | 1 | 10 | 10 (100) | 0 | 0 |
| HIV+/OND | 4 | 24 | 8 (33) | 14 (58) | 2 (8) | |||||
| Total | 11 | 79 | 10 | 98 | ||||||
a
A, archetype; AL, archetype like; TR, tandem repeats.